Disruptive Technologies for Drugging the Undruggable
October 1, 2025 @ 09:00 – 17:00 CEST
SciLifeLab Science Summit 2025

Are you ready to explore the cutting-edge for the future of drug discovery? Mark your calendar for the SciLifeLab Science Summit 2025, an event focusing on novel technologies as drivers to find new modalities for disease intervention and drug innovation for precision medicine.
This full-day symposium will bring together leading scientists, industry experts, and innovators to discuss the breakthroughs and challenges in addressing previously inaccessible drug targets. Join us at Aula Medica, Karolinska Institutet, for a packed program featuring high-impact international presentations, panel discussions, and networking opportunities.
Junior researchers are encouraged to participate with poster presentations – with the opportunity to be selected to give a short talk.
Program
| 08:45 | Registration |
| 09:30 | Welcome words Introduction of the day |
| 09:40 | SciLifeLab – a fertile ground for innovation Mia Phillipson, SciLifeLab |
| 09:50 | Any target, every time: how proximity-based drugs are redefining pharmacotherapy Ray Deshaies, Amgen / Caltech |
| 10:40 | Coffee break & poster session I See Poster List & Abstracts here |
| 11:25 | Applying lessons learned from Duchenne exon skipping dystrophy to developing exon skipping for patients with nanorare diseases Annemieke Aartsma-Rus, Leiden University Medical Center |
| 12:00 | Oligonucleotide therapy – from bench to beside Anders Gabrielsen, Ribocure Pharmaceuticals |
| 12:10 | Empowering immunotherapy with cellular reprogramming Filipe Pereira, Lund university |
| 12:20 | Conclusions |
| 12:30 | Lunch & Poster Session |
| 13:40 | AI and machine learning for next-generation drug discovery Eva Nittinger, AstraZeneca |
| 14:10 | Electrophoretic Implants for in situ Precision Medicine Theresia Arbring Sjöström, Linköping University |
| 14:15 | Integrated Hit Discovery Pipeline Targeting Protein–Protein Interactions Florian David, Chalmers University of Technology |
| 14:20 | Employing CETSA in primary screening for P53 binders Merve Kacal, Pelago Bioscience AB |
| 14:25 | Capturing Conformational Change : A Strategy for Drugging Dynamic Transporters, Receptors and Ion Channels Darko Mitrovic, KTH Royal Institute of Technology |
| 14:30 | Conclusions |
| 14:40 | Coffee break & poster session II See poster list and abstract here |
| 15:30 | Encoded combinatorial libraries and the dream of Paul Ehrlich Dario Neri, Philogen / ETHZ |
| 16:00 | The 2025 Drug Discovery and Development Pipeline Jessica Martinsson, SwedenBio |
| 16:20 | Panel discussion |
| 16:40 | Wrap-up, best poster award |
| 17:00 | Mingle |
Research Infrastructures and Research Posters
Company Exhibition
15 companies will present their technologies in the exhibition area.
BICO, Epistat, Sino Biological Europe GmbH, Chempartner, Ramcon, Twist Bioscience, Shimadzu, Teknolab Sorbent AB, BioNordika Sweden AB, Berner Lab, Kem-En-Tec Nordic , Eppendorf Nordic, LabLife Nordic
Scientific Committee
- Claes Wahlestedt, University of Miami
- Malin Lemurell, AstraZeneca
- Alexandra Teleki, Uppsala University
Organizing Committee
- Per Arvidsson, Karolinska Institutet/SciLifeLab
- Rebecka Klintenberg, Uppsala University/SciLifeLab
- Mats Ohlin, Lund University/SciLifeLab
- Kristian Sandberg, Uppsala University/SciLifeLab
- Contact: David Gotthold, SciLifeLab

